3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
19
OTHER_GOV
2
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Breast
1
Conditions
Mucositis
27
Opioid-Induced Constipation
20
Constipation
18
Head and Neck Neoplasms
14
Stomatitis
13
Pain
12
Neoplasms
7
Obesity
6
Intestinal Diseases
5
Bronchiolitis Obliterans Syndrome
5
Oral Ulcer
3
Lymphoma, Follicular
3
Hematologic Neoplasms
3
Chemotherapy-induced Peripheral Neuropathy
3
Breast Neoplasms
3
Xerostomia
2
Venous Thromboembolism
2
Tumor Lysis Syndrome
2
Thrombocytopenia
2
Teratogenesis
2
Sexual Dysfunctions, Psychological
2
Sexual Dysfunction, Physiological
2
Renal Insufficiency
2
Prostatic Neoplasms
2
Peripheral Nervous System Diseases
2
Overweight
2
Obesity, Morbid
2
Neutropenia
2
Myocardial Infarction
2
Myelodysplastic Syndromes
2
Interventions
licogliflozin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Insulin Resistance
×
Other
×
Clear all
NCT03152591
2021-01-05
PCOS
Novartis
Phase 2
Completed
29 enrolled
24 charts